Consecutive patients meeting the inclusion criteria and treated as inpatients or treated in the anticoagulation bridging clinic at SHMC between January 1, 1999, and August 31, 2000, were selected for ...

Thiotepa-Based High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Patients With Recurrent or Progressive CNS Germ Cell Tumors Patients with advanced malignancy (N = 385) were randomly assigned ...

Thromboembol in blood vessel. Clot formation, 3D illustration Researchers sought to compare oral apixaban and subcutaneous dalteparin for treating patients with cancer-related venous thromboembolism.

For people with cancer, the oral blood thinner apixaban is at least as effective as dalteparin, a low molecular weight heparin given by injection, in preventing a repeat venous thromboembolism (VTE), ...

This trial wanted to see if the blood thinning drug dalteparin (Fragmin) could reduce the number of blood clots people had during treatment for lung cancer. And to find out if it could help stop ...

The US Food and Drug Administration has approved dalteparin sodium (Fragmin; Pfizer) as the first anticoagulant indicated for use in pediatric patients older than 1 month to reduce the risk of ...

Please provide your email address to receive an email when new articles are posted on . Treatment of venous thromboembolism with oral apixaban was noninferior to subcutaneous dalteparin, without ...

The introduction of low-molecular-weight heparins (LMWHs) was a watershed event in the treatment of thrombotic disorders. LMWHs differ from unfractionated heparin (UFH) in that they have excellent ...